Alexion to buy Wilson for $855m
Alexion Pharmaceuticals has offered to buy Wilson Therapeutics in a deal worth around $855 million.
Read More
Tag: WTX101
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
